Skip to main content
Themis Medicare Ltd. logo

Themis Medicare Ltd. — Investor Relations & Filings

Ticker · THEMISMED ISIN · INE083B01024 LEI · 335800LHRDVIKH69AF42 BSE.NS Manufacturing
Open in API
Filings indexed 707 across all filing types
Latest filing 2023-08-17 Investor Presentation
Country IN India
Listing BSE.NS THEMISMED

About Themis Medicare Ltd.

https://www.themismedicare.com/

Themis Medicare Ltd. is a research-driven pharmaceutical organization specializing in the development, manufacture, and marketing of a diverse range of therapeutic products. The company focuses on high-value segments including pain management, anesthesia, critical care, anti-infectives, and oncology. Its core competencies lie in the production of Active Pharmaceutical Ingredients (APIs) and complex finished dosage formulations, particularly injectables. Themis Medicare maintains a strong emphasis on Research and Development, operating state-of-the-art facilities that adhere to international quality standards such as WHO-GMP. Through strategic partnerships and a robust supply chain, the company serves both domestic and international markets, providing specialized medical solutions for hospital-based care and chronic disease management. Its portfolio includes proprietary delivery systems and differentiated generic products designed to improve patient outcomes.

Recent filings

Filing Released Lang Actions
Investor Presentation
Investor Presentation Classification · 100% confidence The document is titled 'Investor Presentation Q1 FY24' and is addressed to stock exchanges (BSE and NSE) as per SEBI regulations. It contains detailed financial highlights for Q1 FY24, including consolidated quarterly and annual financial data, management commentary, business overview, and strategic focus. The document is about 15,000 characters long, which is consistent with a detailed presentation rather than a brief announcement. It explicitly states it is an 'Investor Presentation' and includes forward-looking statements and disclaimers typical of investor presentations. There is no indication that this is a full annual or interim report, audit report, or earnings release. It is not a regulatory filing or announcement of a report publication but the actual presentation document. Therefore, the document fits the category of an Investor Presentation (IP).
2023-08-17 English
Updates
Environmental & Social Information Classification · 100% confidence The document is titled 'Business Responsibility & Sustainability Report' and contains detailed disclosures about the company's environmental, social, and governance (ESG) practices, including product quality, occupational health and safety, regulatory compliance, product innovation, and sustainable supply chain management. It includes data on employees, operations, markets served, and CSR details. The content focuses on the company's performance and initiatives related to sustainability and social responsibility rather than financial results or governance changes. The document length is substantial (15,000 characters), indicating it is a full report rather than a brief announcement. Therefore, the document fits the category of Environmental & Social Information (SR).
2023-08-16 English
Updates
Regulatory Filings
2023-08-16 English
Shareholders meeting
Regulatory Filings
2023-08-16 English
Updates
Legal Proceedings Report Classification · 95% confidence The document is an intimation under Regulation 30 and 30A of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. It details pending material litigations and disputes involving the company, including financial implications and current status. The document is addressed to stock exchanges (BSE and NSE) and is a formal disclosure of legal proceedings affecting the company. It does not contain full financial statements or detailed management discussion but focuses on legal matters. Therefore, it fits the category of Legal Proceedings Report (LTR). The document length (8019 characters) is sufficient to contain substantive information, not just a brief announcement or certification.
2023-08-14 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) dated 11th August 2023, referencing the publication of an extract of unaudited standalone and consolidated financial results for the quarter ended 30th June 2023. It mentions compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 47 and Regulation 30. The letter encloses copies of newspaper advertisements where the financial results were published. The document does not contain the full financial statements or detailed financial analysis but rather is an announcement that the financial results extract has been published in newspapers. This fits the pattern of a Regulatory Filing (RNS) as it is a regulatory announcement about the publication of financial results, not the full financial report itself. The document length is about 12,434 characters, but the content is primarily an announcement and newspaper advertisement extract, not a full report. Therefore, the correct classification is Regulatory Filings (RNS).
2023-08-11 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.